Focus Middle East and India

The Indian pharmaceutical industry has made great progress and moved up the value chain from generics to discovery based R&D.  FOCUS wants to serve the Indian pharmaceutical industry and be their partner in the unique opportunity of developing new compounds, bridging India to Europe and major Western markets.

FOCUS Clinical Drug Development GmbH (www.focus-cdd.de) is an independent full service drug development house. The unique combination of drug development and clinical pharmacology know-how, together with an in-house infrastructure to support every aspect of the program including the conduct of the clinical studies ensures fast results in best quality and European standard.

We provide product consultancy, development planning with regulatory strategy for new chemical/biological entities, herbal products, generics plus and drug combinations (FDC).

FOCUS HQ is located in Neuss/Duesseldorf, Germany with affiliates in Heidelberg, Belgrade, Moscow, Jakarta and Dubai. Since inception by MBO from SmithKline Beecham more than 15 years ago it has successfully grown to become an established provider of comprehensive NCE/NBE development services to global pharmaceutical and biotech companies.

We FOCUS on:

• Regulatory path finding and development planning
• Integrated project management for a comprehensive and
  internationally accepted data package
• Clinical proof of concept studies
• Full service up to registration for fixed dose combinations and value added Generics
• Valuation of R&D portfolio and strategic advice
• In-licensing service: providing early stage molecules to fill gaps in R&D portfolio
• Out-licensing  service: commercialization of in-house molecules to global Big Pharma